ProQR Therapeutics (PRQR) Free Cash Flow (QoQ) (2013 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3.84% |
| Sep 30, 2022 | 2.24% |
| Jun 30, 2022 | 31.30% |
| Mar 31, 2022 | -594.78% |
| Dec 31, 2021 | 149.35% |
| Sep 30, 2021 | 22.25% |
| Jun 30, 2021 | 15.50% |
| Mar 31, 2021 | -1.96% |
| Dec 31, 2020 | -24.44% |
| Sep 30, 2020 | 0.19% |
| Jun 30, 2020 | -68,238.33% |
| Mar 31, 2020 | 99.87% |
| Dec 31, 2019 | -33.36% |
| Sep 30, 2019 | 19.80% |
| Jun 30, 2019 | 12.13% |
| Mar 31, 2019 | -133,111.63% |
| Dec 31, 2018 | 99.79% |
| Sep 30, 2018 | 22.69% |
| Jun 30, 2018 | -89,181,924.37% |
| Mar 31, 2018 | -99.93% |
| Dec 31, 2017 | 84,035.26% |
| Sep 30, 2017 | 100.00% |
| Jun 30, 2017 | -115,812.50% |
| Mar 31, 2017 | 100.02% |
| Dec 31, 2016 | -342,544.19% |
| Dec 31, 2015 | -404,874.40% |
| Mar 31, 2015 | 3.10% |
| Dec 31, 2014 | -6.33% |
| Mar 31, 2014 | -71.00% |
| Dec 31, 2013 | -78.23% |